State Street Corporation 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 1:20 pm Sale | 2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 337,491 1.950% | -50,315 (-12.97%) | Filing |
| 2022-10-11 2:06 pm Sale | 2022-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 387,807 2.240% | -2,006,750 (-83.80%) | Filing |
| 2022-07-11 11:46 am Purchase | 2022-06-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 2,394,557 13.920% | 1,537,976 (+179.55%) | Filing |
| 2022-02-11 7:55 pm Sale | 2021-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 856,581 5.010% | -79,669 (-8.51%) | Filing |
| 2021-02-11 07:18 am Purchase | 2020-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 936,250 5.540% | 936,250 (New Position) | Filing |